• Skip to primary navigation
  • Skip to main content
  • Skip to footer
United Health Products Inc Logo

United Health Products, Inc.

Innovative health products for the management of complicated bleeds.

  • Home
  • About
    • Leadership
    • Code of Ethics
  • Products
  • Careers
  • Investors
  • News
    • Press Releases
  • Contact
Home » Press Releases » Page 4

Press Releases

United Health Products Provides Update on FDA PMA Application

November 28, 2022

Mesquite, Nevada – Nov 28, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application.   UHP continues to advance its Premarket Approval application with the Food and Drug Administration. As described in its October 31 press release, the company has completed its review and documentation […]

Filed Under: Press Releases

United Health Products Provides Update on FDA PMA Application

October 31, 2022

Mesquite, NV, – Oct. 31, 2022 – United Health Products, Inc. (OTCPK: UEEC) (UHP), today provided an update on the company’s FDA Premarket Approval application and financial reporting calendar.   As previously disclosed in its press release of September 6th, UHP continues to assemble required documentation and test its manufacturing process to complete its FDA application for […]

Filed Under: Press Releases

United Health Products Announces Equity Financing Agreement and Provides Corporate Update

September 6, 2022

Mesquite, Nevada – September 6, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today announced that it has entered into a common stock purchase agreement to sell up to $10 million of shares to White Lion Capital, LLC (White Lion), a California-based institutional investor. Under the terms of the purchase agreement, UHP will have the […]

Filed Under: Press Releases

United Health Products Provides Update on FDA Review

July 15, 2022

Henderson, Nevada – July 15, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application.   On July 13 the company and its regulatory consultant met with the full FDA team assigned to review its Class III PMA application. The focus of the meeting was […]

Filed Under: Press Releases

United Health Products Announces Settlement of SEC Investigation

June 16, 2022

Henderson, Nevada – June 16, 2022 – United Health Products, Inc. (OTCPK: UEEC) (UHP), today announced a final settlement of the SEC investigation initially reported by the Company in its Annual Report on Form 10-K for the year ended December 31, 2021.   UHP has agreed with the Securities and Exchange Commission (the Commission) to […]

Filed Under: Press Releases

United Health Products Provides Regulatory Update

May 18, 2022

Henderson, Nevada – May 18, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its FDA regulatory process.   Regulatory Review As previously disclosed, on April 20, 2022, UHP delivered to the U.S. Food & Drug Administration (FDA) a supplemented and e-formatted Premarket Approval (PMA) response for its HemoStyp™ hemostatic […]

Filed Under: Press Releases

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Go to Next Page »

Footer

Our Locations

Corporate Headquarters
520 Fellowship Road, Suite #D-406
Mt. Laurel, NJ 08054

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy

Contact Us

General Contact
info@uhpcorp.com
475.755.1005

Follow Us

  • Email
  • YouTube
  • Legal
  • Privacy Policy

Copyright © 2025 · United Health Products, Inc. All Rights Reserved. Website by Cindy Leigh Media